Resources

This document sets out the findings of a 3 month pharmacy testing pilot.

This commissioning policy paper was produced for the treatment of patients with Hepatitis C in the East Midlands, with the aim of providing and ensuring equity, consistency and clarity in approach to treatment across the region. The document sets out the position of East Midlands Specialised Commissioning Group PCTs in respect of treatment for Hepatitis C for its current and future patients, outlining the treatment regimens for the various different genotypes of Hepatitis C using combination therapy (pegylated interferon alpha and weight-based ribavirin).

This document reviews the current landscape of UK liver disease and advises the Department of Health on ways to improve liver services and the outcomes of liver disease in the UK. It stresses the fact that radical change in the profile of the disease is achievable, and includes recommendations on cost-effective and high quality management of liver disease and liver services, the establishment of training frameworks and the setting of clinical standards, quality metrics and guidelines for the monitoring and assessment of local services.

In response to the public health challenge of Hepatitis C, national Governments in England, Scotland and Wales have taken radically different approaches. The All-Party Parliamentary Hepatology Group convened a meeting to explore the impact of the different national strategies. The meeting provided an opportunity for Parliamentarians, experts and stakeholders to compare and contrast the effectiveness of each approach and identify areas of best practice, which can be shared across national borders.